Efalizumab and condition aggravated 
Efalizumab and condition aggravated Patient Reports February 11, 2012
Efalizumab Side Effects Report #5612232-5
Efalizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 31, 2008. Female patient was diagnosed with sweat gland infection, lactose intolerance
and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: breast cancer , condition aggravated, pyrexia, sweat gland infection, vomiting. Efalizumab dosage: 0.7 ML, X2. During the same period patient was treated with COREG, DAIRYCARE. Patient recovered.Efalizumab Side Effects Report #5050816-6
Efalizumab side effect was reported by a Physician from MEXICO on June 28, 2006. Female patient, 72 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: anxiety
, condition aggravated, insomnia, psoriasis, suicidal ideation. Efalizumab dosage: 1 MG/KG, 1/WEEK, SUBCUTANEOUS. Patient was hospitalized. Patient recovered.Efalizumab Side Effects Report #4664768-1
Efalizumab side effect was reported by a Physician from on May 03, 2005. Female patient, 72 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: anxiety
, condition aggravated, insomnia, pruritus, psoriasis, suicidal ideation. Efalizumab dosage: 1 MG/KG, 1/WEEK, SUBCUTANEOUS. Patient was hospitalized. Patient recovered.Efalizumab Side Effects Report #4698372-6
Efalizumab side effect was reported by a Health Professional from on June 17, 2005. Female patient, 72 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: anxiety
, condition aggravated, insomnia, pruritus, psoriasis, suicidal ideation. Efalizumab dosage: 1 MG/KG, 1/WEEK, SUBCUTANEOUS. Patient was hospitalized. Patient recovered.Efalizumab Side Effects Report #5054092-X
Efalizumab side effect was reported by a Consumer or non-health professional from BRAZIL on June 28, 2006. Male patient, 56 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: benign prostatic hyperplasia, condition aggravated, erectile dysfunction
, prostate cancer , prostatic specific antigen increased, psoriasis. Efalizumab dosage: 0.8 ML, 1/WEEK, SUBCUTANEOUS. Patient recovered.Efalizumab Side Effects Report #4807732-1
Efalizumab side effect was reported by a Health Professional from FRANCE on Oct 05, 2005. Male patient, 56 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: cheilitis, condition aggravated, conjunctivitis, keratitis, photosensitivity reaction, psoriasis. Efalizumab dosage: 1 MG/KG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with COAPROVEL. Patient was hospitalized. Patient recovered.
Efalizumab Side Effects Report #4890634-2
Efalizumab side effect was reported by a Physician from BRAZIL on Jan 06, 2006. Male patient, 56 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: condition aggravated, erectile dysfunction
, prostate cancer , psoriasis. Efalizumab dosage: 0.8 ML, 1/WEEK, SUBCUTANEOUS. Patient recovered.Efalizumab Side Effects Report #4906744-7
Efalizumab side effect was reported by a Consumer or non-health professional from SWITZERLAND on Jan 26, 2006. Male patient, 56 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: condition aggravated, erectile dysfunction
, neoplasm prostate, psoriasis. Efalizumab dosage: 0.8 ML, 1/WEEK, SUBCUTANEOUS. Patient recovered.Efalizumab Side Effects Report #4933997-1
Efalizumab side effect was reported by a Health Professional from BRAZIL on Feb 22, 2006. Male patient, 56 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: benign prostatic hyperplasia, condition aggravated, erectile dysfunction
, neoplasm prostate, prostatic specific antigen increased, psoriasis. Efalizumab dosage: 0.8 ML, 1/WEEK,. Patient recovered.Efalizumab Side Effects Report #4777144-8
Efalizumab side effect was reported by a Physician from UNITED KINGDOM on Sept 02, 2005. Female patient, 54 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: blood glucose decreased, blood glucose increased, condition aggravated, loss of consciousness, pharyngolaryngeal pain, psoriasis, rash papular, syncope vasovagal, viral infection
. Efalizumab dosage: 1 MG/KG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with NAPROSYN. Patient was hospitalized. Patient recovered.Efalizumab Side Effects Report #4988898-X
Efalizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 14, 2006. Male patient, 54 years of age, was diagnosed with psoriasis, crohn's disease
and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: cd4 lymphocytes increased, cd8 lymphocytes increased, condition aggravated, crohn's disease , dermatitis, mycosis fungoides, psoriasis, rash pruritic. Efalizumab dosage: 1 MG/KG, SUBCUTANEOUS. During the same period patient was treated with INFLIXIMAB. Patient recovered.Efalizumab Side Effects Report #4622183-0
Efalizumab side effect was reported by a Consumer or non-health professional from on Mar 21, 2005. Male patient, 48 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: atelectasis, condition aggravated, pancreatitis, psoriasis. Efalizumab dosage: 1MG/KG, 1 WEEK, SUBCUTANEOUS. During the same period patient was treated with HYDROCORTISONE, SIMVASTATIN. Patient was hospitalized. Patient recovered.
Efalizumab Side Effects Report #4838331-3
Efalizumab side effect was reported by a Health Professional from SWITZERLAND on Nov 08, 2005. Male patient, 48 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: arthralgia, condition aggravated, erythrodermic psoriasis, lymphadenopathy, psoriatic arthropathy, pyrexia, synovial cyst. Efalizumab dosage: 1 MG/KG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with MOXONIDINE, IRBESARTAN, ALLOPURINOL, CLOTRIMAZOLE. Patient was hospitalized. Patient recovered.
Efalizumab Side Effects Report #4899529-1
Efalizumab side effect was reported by a Physician from GERMANY on Jan 17, 2006. Male patient, 48 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: condition aggravated, erythrodermic psoriasis, lymphadenopathy, psoriatic arthropathy, pyrexia, synovial cyst. Efalizumab dosage: 1MG/KG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with MOXONIDINE, IRBESARTAN, ALLOPURINOL, CLOTRIMAZOLE. Patient was hospitalized. Patient recovered.
Efalizumab Side Effects Report #4998727-6
Efalizumab side effect was reported by a Physician from GERMANY on May 05, 2006. Male patient, 48 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: arthralgia, condition aggravated, erythrodermic psoriasis, lymphadenopathy, psoriatic arthropathy, pyrexia, synovial cyst. Efalizumab dosage: 1 MG/KG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with MOXONIDINE, IRBESARTAN, ALLOPURINOL, CLOTRIMAZOLE. Patient was hospitalized. Patient recovered.
Efalizumab Side Effects Report #5050817-8
Efalizumab side effect was reported by a Physician from SWITZERLAND on June 29, 2006. Male patient, 46 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: arthralgia, arthritis
, asthenia, asthma , basophil count increased, blood potassium increased, condition aggravated, eosinophil count increased, hypertension. Efalizumab dosage: 0.142 MG/KG, 1/WEEK, SUBCUTANEOUS. Patient was hospitalized. Patient recovered.Efalizumab Side Effects Report #5122588-8
Efalizumab side effect was reported by a Consumer or non-health professional from BRAZIL on Sept 22, 2006. Male patient, 46 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: arthritis
, asthenia, asthma , basophil count increased, blood potassium increased, condition aggravated, eosinophil count increased, hypertension, hypochromic anaemia. Efalizumab dosage: 0.142 MG/KG, 1/WEEK, SUBCUTANEOUS. Patient was hospitalized. Patient recovered.Efalizumab Side Effects Report #4836678-8
Efalizumab side effect was reported by a Health Professional from SWITZERLAND on Nov 03, 2005. Male patient, 46 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: arthralgia, asthenia, asthma
, blood potassium increased, condition aggravated, eosinophil count increased, hypochromic anaemia, myalgia, oedema peripheral. Efalizumab dosage: 0.142 MG/KG, 1/WEEK, SUBCUTANEOUS. Patient was hospitalized. Patient recovered.Efalizumab Side Effects Report #4852003-0
Efalizumab side effect was reported by a Consumer or non-health professional from BRAZIL on Nov 23, 2005. Male patient, 46 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: anaemia, arthralgia, asthenia, asthma
, basophil count increased, blood potassium increased, condition aggravated, eosinophil count increased, hypertension. Efalizumab dosage: 0.142 MG/KG, 1/WEEK, SUBCUTANEOUS. Patient was hospitalized. Patient recovered.Efalizumab Side Effects Report #4917796-2
Efalizumab side effect was reported by a Physician from BRAZIL on Jan 30, 2006. Male patient, 46 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: anaemia, arthralgia, arthritis
, asthenia, asthma , blood potassium increased, condition aggravated, hypertension, lymphadenopathy. Efalizumab dosage: 0.142 MG/KG, 1/WEEK, SUBCUTANEOUS. Patient was hospitalized. Patient recovered.Efalizumab Side Effects Report #4998726-4
Efalizumab side effect was reported by a Physician from BRAZIL on May 05, 2006. Male patient, 46 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: arthritis
, asthenia, asthma , basophil count increased, blood potassium increased, condition aggravated, eosinophil count increased, hypertension, hypochromic anaemia. Efalizumab dosage: 0.142 MG/KG, 1/WEEK. Patient was hospitalized. Patient recovered.Efalizumab Side Effects Report #5090729-7
Efalizumab side effect was reported by a Physician from UNITED KINGDOM on Aug 15, 2006. Male patient, 43 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: condition aggravated, dermatitis, hyperkeratosis, lymphocytosis, parakeratosis, psoriasis, rash erythematous, rash pruritic, skin erosion. Efalizumab dosage: 0.142 MG/KG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with CALCIPOTRIOL, AQUEOUS CREAM. Patient recovered.
Efalizumab Side Effects Report #5107058-5
Efalizumab side effect was reported by a Consumer or non-health professional from SWITZERLAND on Sept 05, 2006. Male patient, 43 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: condition aggravated, dermatitis, hyperkeratosis, lymphocytosis, parakeratosis, psoriasis, rash erythematous, rash pruritic, skin erosion. Efalizumab dosage: 0.142 MG/KG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with CALCIPOTRIOL, AQUEOUS CREAM. Patient was hospitalized. Patient recovered.
Efalizumab Side Effects Report #5159329-4
Efalizumab side effect was reported by a Health Professional from UNITED KINGDOM on Nov 03, 2006. Male patient, 43 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: blood cholesterol increased, blood pressure systolic increased, condition aggravated, dermatitis, hyperkeratosis, lymphocytosis, psoriasis, skin erosion. Efalizumab dosage: 0.142 MG/KG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with CALCIPOTRIOL, AQUEOUS CREAM. Patient was hospitalized. Patient recovered.
Efalizumab Side Effects Report #5123396-4
Efalizumab side effect was reported by a Physician from BRAZIL on Sept 25, 2006. Female patient, 34 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: bile duct stone, cholecystitis chronic, cholelithiasis, condition aggravated. Efalizumab dosage: 1 MG/KG, 1/WEEK, SUBCUTANEOUS. Patient was hospitalized. Patient recovered.
Efalizumab Side Effects Report #4583577-5
Efalizumab side effect was reported by a Physician from on Feb 04, 2005. Female patient, 34 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: abdominal pain upper, cholecystitis chronic, condition aggravated, pyrexia. Efalizumab dosage: 1 MG/KG, 1/WEEK, SUBCUTANEOUS. Patient was hospitalized. Patient recovered.
Efalizumab Side Effects Report #4597241-X
Efalizumab side effect was reported by a Health Professional from on Feb 16, 2005. Female patient, 34 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: cholecystitis chronic, condition aggravated. Efalizumab dosage: 1 MG/KG, 1/WEEK, SUBCUTANEOUS. Patient was hospitalized. Patient recovered.
Efalizumab Side Effects Report #4650485-0
Efalizumab side effect was reported by a Health Professional from on Apr 25, 2005. Male patient, 31 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, condition aggravated, cough, cytomegalovirus antibody positive, cytomegalovirus infection
, dyspnoea. Efalizumab dosage: 1MG/KG, 1/WEEK, SUBCUTANEOUS. Patient recovered.Efalizumab Side Effects Report #4832091-8
Efalizumab side effect was reported by a Health Professional from SWITZERLAND on Nov 08, 2005. Male patient, 31 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: blood chloride abnormal, condition aggravated, csf lymphocyte count increased, csf protein increased, csf test abnormal, csf white blood cell count increased, diplopia, influenza like illness, myelitis transverse. Efalizumab dosage: 1 MG/KG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with CLOBETASOL OINTMENT, PETROLEUM JELLY, LORATADINE, HYDROXYZINE, SOFT PARAFFIN. Patient was hospitalized. Patient recovered.
Efalizumab Side Effects Report #5129042-8
Efalizumab side effect was reported by a Health Professional from UNITED STATES on Sept 22, 2006. Male patient, 28 years of age, weighting 155.4 lb, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: anaemia, anorexia, arthralgia, asthenia, calcinosis, condition aggravated, diverticulum intestinal, granuloma, haemangioma of liver. Efalizumab dosage: 1 MG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with PREDNISONE, CYCLOSPORINE, REMICADE, BENADRYL. Patient was hospitalized. Patient recovered.
Efalizumab Side Effects Report #5179367-5
Efalizumab side effect was reported by a Health Professional from UNITED STATES on Dec 05, 2006. Male patient, 28 years of age, weighting 155.4 lb, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: anaemia, anorexia, asthenia, condition aggravated, diverticulum intestinal, haemangioma, inflammation, liver disorder, platelet count increased. Efalizumab dosage: 1 MG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with PREDNISONE, CYCLOSPORINE, REMICADE, BENADRYL. Patient was hospitalized. Patient recovered.